HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS

被引:4
作者
AASEBO, U [1 ]
SLORDAL, L [1 ]
PRYTZ, PS [1 ]
AARBAKKE, J [1 ]
机构
[1] UNIV TROMSO,INST MED BIOL,DEPT PHARMACOL,N-9001 TROMSO,NORWAY
来源
PHARMACOLOGY & TOXICOLOGY | 1987年 / 60卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1987.tb01522.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:337 / 339
页数:3
相关论文
共 15 条
[1]   EMESIS DUE TO CANCER-CHEMOTHERAPY - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND TRIAL OF VARYING DOSES OF METOCLOPRAMIDE IN THE MANAGEMENT OF CIS-PLATINUM-INDUCED VOMITING [J].
ALLAN, SG ;
CORNBLEET, MA ;
LOCKHART, SP ;
WARRINGTON, PS ;
LEONARD, RCF ;
SMYTH, JF .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (12) :1481-1484
[2]  
CREESE I, 1983, NEUROLEPTICS NEUROCH, P183
[3]   ANTI-EMETIC EFFICACY OF HIGH-DOSE METOCLOPRAMIDE - RANDOMIZED TRIALS WITH PLACEBO AND PROCHLORPERAZINE IN PATIENTS WITH CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING [J].
GRALLA, RJ ;
ITRI, LM ;
PISKO, SE ;
SQUILLANTE, AE ;
KELSEN, DP ;
BRAUN, DW ;
BORDIN, LA ;
BRAUN, TJ ;
YOUNG, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (16) :905-909
[4]   METOCLOPRAMIDE - A REVIEW OF ANTI-EMETIC TRIALS [J].
GRALLA, RJ .
DRUGS, 1983, 25 :63-73
[5]   ANTIEMETIC TREATMENT [J].
GRALLA, RJ .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (02) :155-157
[6]  
GRALLA RJ, 1981, TREATMENT CANCER CHE, P167
[7]   CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE FOR THE PREVENTION OF NAUSEA AND VOMITING IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].
JOSS, RA ;
GALEAZZI, RL ;
BRUNNER, KW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (01) :35-39
[8]   THE RELATIONSHIP BETWEEN STEADY-STATE METOCLOPRAMIDE LEVELS AND CONTROL OF EMESIS DURING TREATMENT WITH CIS-PLATINUM [J].
KERR, DJ ;
GRAHAM, J ;
BLACKIE, RG ;
MCGOVERN, E ;
KELMAN, AW ;
CUNNINGHAM, D ;
KAYE, SB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 20 (04) :426-427
[9]  
KRIS MG, 1985, CANCER, V55, P527, DOI 10.1002/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO
[10]  
2-2